Faron Pharmaceuticals Oy (LON:FARN – Get Free Report)’s stock price crossed below its fifty day moving average during trading on Wednesday . The stock has a fifty day moving average of GBX 42.71 and traded as low as GBX 40.15. Faron Pharmaceuticals Oy shares last traded at GBX 40.15, with a volume of 15,908 shares.
Faron Pharmaceuticals Oy Stock Down 4.8%
The stock has a market capitalization of £79.23 million, a P/E ratio of -1.77 and a beta of 1.12. The company has a current ratio of 0.84, a quick ratio of 1.09 and a debt-to-equity ratio of -133.35. The firm’s fifty day moving average is GBX 42.53 and its 200-day moving average is GBX 68.98.
About Faron Pharmaceuticals Oy
Faron (AIM: FARN, First North: FARON) is a clinical stage biopharmaceutical company developing novel treatments for medical conditions with significant unmet needs. The Company currently has a pipeline based on the receptors involved in regulation of immune response in oncology and organ damage. Clevegen (bexmarilimab), its investigative precision immunotherapy, is a novel anti-Clever-1 antibody with the ability to switch immune suppression to immune activation in various conditions, with potential across oncology, infectious disease and vaccine development.
Further Reading
- Five stocks we like better than Faron Pharmaceuticals Oy
- AMD and Cerbras Create A New Blueprint For Hardware
- Intel Earnings Reveal Whether the Chip Selloff Created a Buy
- CrowdStrike’s Cerebras Deal Puts Its AI Security Strategy to the Test
- Plugging In: How Kinder Morgan Powers Up Profits
Receive News & Ratings for Faron Pharmaceuticals Oy Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Faron Pharmaceuticals Oy and related companies with MarketBeat.com's FREE daily email newsletter.
